Francis Pang

Senior Vice President, Global Market Access & New Market Expansion, Committee Member & Economic Lead, NICE • Orchard Therapeutics

Francis Pang is Vice President and Head, Global Market Access at Orchard Therapeutics and has more than 20 years of experience in pricing and reimbursement, market access and health economics, encompassing leadership roles at Amicus Therapeutics, Biogen and Shire HGT. In recognition of his expertise related to rare diseases, Francis has served as the healthcare industry representative on the NICE Highly Specialised Technologies (HST) Committee since its inception. He also co-chairs the European Market Access and Value Committee of the Alliance for Regenerative Medicine (ARM). Prior to joining the biopharmaceutical industry, Francis was the inaugural Pharmacoeconomics Research Fellow at the Centre for Health Economics, University of York, UK and Monbusho Scholar at Kyoto University, Japan. Francis holds degrees in genetics and health economics, together with an MBA from INSEAD and certification in the management of biotech ventures from École Polytechnique Fédérale de Lausanne (EPFL).

Also speaking

Ben Weil

Head of GMP Engineering at Royal Free London NHS Foundation Trust • NHS England

Jenny Stjernberg

EMEA Commercial Director • ScaleReady

Paolo Morgese

Head of Public Affairs, Europe • Alliance for Regenerative Medicine

Event Info


Event Brochure

Take a look at the 2023 Event Brochure for Advanced Therapies Europe.

Download the 2023 Speaker List

Download the 2023 Speaker List for Advanced Therapies Europe here.